23 October 2017
News and Views
Links and Services
Gastroenterologists have suboptimal Hep B virus screening rates in patients receiving immunosuppressive therapy, finds this month's Digestive Diseases & Sciences.
Hepatitis B reactivation in patients undergoing immunosuppressive therapy can lead to liver failu
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors